Q3 2025 Tactile Systems Technology Inc Earnings Call Transcript
Key Points
- Tactile Systems Technology Inc (TCMD) reported a strong third quarter with total revenue of $85.8 million, representing a 17% year-over-year growth.
- The company saw significant growth in its airway clearance revenue, which increased by 71% year over year to $13.4 million.
- Gross margins improved by 80 basis points year over year to 76%, indicating better cost management and operational efficiency.
- The company raised its full-year 2025 total revenue guidance to a range of $317 million to $321 million, reflecting confidence in sustained growth.
- Tactile Systems Technology Inc (TCMD) has successfully expanded its sales force, ending Q3 with 329 total reps, surpassing its year-end goal of 300 reps.
- The commercial and VA channels for lymphedema products saw a decline of 9% year over year, indicating challenges in these segments.
- The company faced headwinds from changes in Medicare documentation requirements, which impacted growth in previous quarters.
- Despite the strong quarter, the company anticipates that the growth rate in the airway clearance business may not be sustainable at the current level into 2026.
- Operating expenses increased by 13% to $54 million, driven by strategic investments, which could pressure margins if not managed carefully.
- The transition from LCD to NCD, while a tailwind, has not yet fully materialized in terms of revenue impact, suggesting potential delays in realizing benefits.
Please stand by. Welcome, ladies and gentlemen to the third quarter of 2025 earnings conference call for Tactile Medical. At this time, all participants have been placed in a listen-only mode.
(Operator Instructions)
I would now like to turn the call over to SAM Bensinger, Investor Relations at Gilmartin Group for a few introductory comments, please go ahead.
Good afternoon and thank you for joining the call today. With me from Tactile's management team are Sheri Dodd, Chief Executive Officer, and Elaine Birkemeyer, Chief Financial Officer.
Before we begin, I'd like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties.
These could cause actual results to differ materially from those indicated, including those identified in the risk factors section of our annual report on Form 10-K, as well as our most recent
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
